(Q40198481)

18 September 2017

The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells (English)

1 reference

18 September 2017

0 references

0 references

0 references

1 reference

Mohan R Dasu

1

1 reference

18 September 2017

Sridevi Devaraj

series ordinal

2

1 reference

18 September 2017

Terry W Du Clos

series ordinal

3

1 reference

18 September 2017

Ishwarlal Jialal

series ordinal

4

1 reference

18 September 2017

9 December 2006

1 reference

Journal of Lipid Research

18 September 2017

1 reference

18 September 2017

48

1 reference

18 September 2017

3

1 reference

18 September 2017

509-512

1 reference

Inflammation and atherosclerosis

18 September 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Coming of age of C-reactive protein: using inflammation markers in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Toll-like receptors and atherosclerosis: key contributors in disease and health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Tlr4: central component of the sole mammalian LPS sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

C-reactive protein: risk marker or mediator in atherothrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C600020-JLR200

10.1194/JLR.C600020-JLR200

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference